Latest News & Features
Europe
Brexit will have significant consequences for the UK regarding SPCs and the unitary patent system, while the UPC’s proposed start date of early 2017 looks highly unlikely, say Christopher Stothers and Paul Abbott of Arnold & Porter. 6 September 2016
Big Pharma
The Francis Crick Institute, Europe’s biggest biomedical research institute, has opened in London. 5 September 2016
Asia
Chugai Pharmaceutical and Fuji Pharma have entered into an agreement to transfer the rights to the manufacture and marketing of cancer drug Vesanoid in Japan. 5 September 2016
Americas
Neos Therapeutics has filed a patent infringement suit against Teva, and its subsidiary Actavis, for allegedly infringing a number of its patents. 2 September 2016
Americas
Japanese pharmaceutical company Otsuka Pharmaceutical has filed a complaint against Indian company Ajanta Pharma for allegedly infringing a patent for its bipolar and schizophrenia medication, Abilify (aripiprazole). 2 September 2016
Americas
Dublin-based pharmaceutical company Allerganhas revealed that its subsidiaries, Forest Laboratories and Adamas Pharmaceuticals, have entered into a settlement agreement with Amneal Pharmaceuticals. 1 September 2016
Americas
The University of Minnesota has sued Gilead Sciences for allegedly infringing the university’s patent by selling drugs containing sofosbuvir. 1 September 2016
Big Pharma
While we await the outcome of the appeal in Warner-Lambert v Actavis, which concerns second medical use patents, there are several steps drugs companies should take given the need to balance the interests of patent owners and generic makers. Clare Greatbanks of Osborne Clarke reports. 1 September 2016
Americas
UK-based company AstraZeneca will have to pay $5.5 million to resolve a bribery case after allegedly falsely rewarding healthcare officials in China and Russia. 31 August 2016
Americas
Diagnostics company Alere has filed a complaint against Abbott in the Delaware Chancery Court in an attempt to compel Abbott to fulfil its obligations surrounding the companies’ merger agreement. 31 August 2016